Patents by Inventor William Timberlake

William Timberlake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plant Genome Sequence and Uses Thereof
    Publication number: 20080113342
    Abstract: The present invention is in the field of plant biochemistry and genetics. More specifically the invention relates to nucleic acid sequences from plant cells, in particular, genomic DNA sequences from Arabidopsis thaliana plants. The invention encompasses nucleic acid molecules present in non-coding regions as well as nucleic acid molecules that encode proteins and fragments of proteins. In addition, the invention also encompasses proteins and fragments of proteins so encoded and antibodies capable of binding these proteins or fragments. The invention also relates to methods of using the nucleic acid molecules, proteins and fragments of proteins, and antibodies, for example for genome mapping, gene identification and analysis, plant breeding, preparation of constructs for use in plant gene expression, and transgenic plants.
    Type: Application
    Filed: February 16, 2000
    Publication date: May 15, 2008
    Applicant: Monsanto Technology LLC
    Inventors: Yongwei CAO, William TIMBERLAKE
  • Identification of antibacterial agents
    Patent number: 6207407
    Abstract: A method for identifying a strain having a conditional lethal mutation which is essential for survival when strain is incubated under restrictive growth, conditions, and methods of identifying gene products and gene functions thereof.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: March 27, 2001
    Assignee: Millenium Pharmaceuticals, Inc.
    Inventors: William Timberlake, Victoria Gavrais
  • Identification of essential survival genes
    Patent number: 5976828
    Abstract: A method for identifying a strain having a conditional lethal mutation which is essential for survival when strain is incubated under restrictive growth conditions, and methods of identifying gene products and gene functions thereof.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: November 2, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: William Timberlake, Victoria Gavrias
  • Identification of essential survival genes
    Patent number: 5821076
    Abstract: A method for identifying a strain having a conditional lethal mutation which is essential for survival when strain is incubated under restrictive growth conditions, and methods of identifying gene products and gene functions thereof.
    Type: Grant
    Filed: March 19, 1998
    Date of Patent: October 13, 1998
    Assignee: Millennium Pharmaceuticals Inc.
    Inventors: William Timberlake, Victoria Gavrias
  • Identification of essential survival genes
    Patent number: 5756305
    Abstract: A method for identifying a strain having a conditional lethal mutation which is essential for survival when strain is incubated under restrictive growth conditions, and methods of identifying gene products and gene functions thereof.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: May 26, 1998
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: William Timberlake, Victoria Gavrias